Efficacy and Safety of Keverprazan Compared With Lansoprazole in the Treatment of Duodenal Ulcer: A Phase III, Randomized, Double-Blind, Multicenter Trial

Keverprazan is a novel potassium-competitive acid blocker for the treatment of acid-related disorders requiring potent acid inhibition. This study aimed to establish the noninferiority of keverprazan to lansoprazole in the treatment of patients with duodenal ulcer (DU). METHODS: In this phase III, d...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Nian-di, Miao, Xin-pu, Liao, Ai-jun, Liu, Cheng-xia, Wu, Hao, Chen, Hong-hui, Li, Fang-fang, Guo, Qing-hong, Li, Sheng-bao, Tang, Yan-ping, Xia, Min, Liu, You-li, Li, Xing, Chen, Hui-xin, Liu, Xiao-wei, Zhang, Yan, Zhang, Zhen-yu, Chen, Min-hu, Xiao, Ying-lian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371330/
https://www.ncbi.nlm.nih.gov/pubmed/37235793
http://dx.doi.org/10.14309/ctg.0000000000000602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371330/
https://www.ncbi.nlm.nih.gov/pubmed/37235793
http://dx.doi.org/10.14309/ctg.0000000000000602

Ejemplares similares